Even though HLA-B*40 was no longer significantly associated with MG after correction; the fact that its frequency was higher among myasthenic patients compared to the general Romanian population suggested that this allele could be a susceptibility marker. This evidence concerns the gene HLA-B and myasthenia gravis.